Elsevier Inc.

SHERPA: Unknown

People

  1. Abu-Rustum
    Abu-Rustum
  2. Chi
    Chi
  3. Lee
    Lee
  4. Giralt
    Giralt
  5. Mulhall
    Mulhall
  6. Perales
    Perales
  7. Sonoda
    Sonoda
  8. Leitao
    Leitao
  9. Yorke
    Yorke
  10. Wu
    Wu

Groups

  1. Department of Medicine (4629)
  2. Surgery (3564)
  3. Survivorship Research (2666)
  4. Solid Tumor Oncology Division (2659)
  5. Radiation Oncology, Department of (2139)
  6. GSK Faculty (1937)
  7. Center for Hematologic Malignancies (1675)
  8. Hematologic Malignancies, Division of (1616)
  9. Gynecology Disease Management Team (1427)
  10. Sloan Kettering Institute Faculty (1398)
Search Within
Formats
  1. Journal Article (7414)
  2. Meeting Abstract (4717)
  3. Review (637)
  4. Book Section (540)
  5. Editorial (256)
  6. Conference Paper (139)
  7. Correspondence (93)
  8. Guidelines (85)
  9. Research Letter (30)
  10. Miscellaneous (15)
  11. Book Whole (14)
Groups
  1. Department of Medicine (4629)
  2. Surgery (3564)
  3. Survivorship Research (2666)
  4. Solid Tumor Oncology Division (2659)
  5. Radiation Oncology, Department of (2139)
  6. GSK Faculty (1937)

More Groups

People
  1. Nadeem Abu-Rustum (464)
  2. Dennis Chi (420)
  3. Nancy Lee (410)
  4. Michael Zelefsky (401)
  5. Sergio Giralt (384)
  6. John Mulhall (378)

More People

Years
  1. 2025 (328)
  2. 2024 (790)
  3. 2023 (760)
  4. 2022 (794)
  5. 2021 (723)
  6. 2020 (716)

More Years

Publications
  1. International Journal of Radiation Oncology, Biology, Physics (2619)
  2. Gynecologic Oncology (1197)
  3. Journal of Thoracic Oncology (970)
  4. Biology of Blood and Marrow Transplantation (815)
  5. European Journal of Cancer (528)
  6. Journal of Sexual Medicine (436)

More Publications

Results (13940)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • What matters most in FIGO IIIA endometrial cancer: Involvement of serosa, adnexa, or both?
    Meeting Abstract

    Rios-Doria, E.; Abu-Rustum, N.; Glaser, G.; McGree, M.; Eriksson, A. G. Z.; Pham, M.; Soliman, P.; Ataseven, B.; Alektiar, K.; Zamarin, D.; more...
    Gynecologic Oncology (2022)

    Fulltext@MSK | Save
  • Oncologic outcomes of secondary cytoreductive surgery in the era of poly (ADP-ribose) polymerase inhibitors maintenance
    Meeting Abstract

    Ehmann, S.; Lam, C.; Zhou, Q.; Grisham, R.; Roche, K. L.; Zivanovic, O.; Sonoda, Y.; Chi, D.; Gardner, G.
    Gynecologic Oncology (2022)

    Fulltext@MSK | Save
  • Molecular and pathologic data can guide selection of endometrioid endometrial cancer patients for ovarian preservation
    Meeting Abstract

    Manning-Geist, B.; Rios-Doria, E.; Liu, Y.; Ellenson, L.; Zhou, Q.; Leitao, M.; Abu-Rustum, N.; Weigelt, B.; Mueller, J.
    Gynecologic Oncology (2022)

    Fulltext@MSK | Save
  • Prognosis of isolated tumor cells and the utility of molecular classification in early stage endometrioid endometrial cancer
    Meeting Abstract

    Rios-Doria, E.; Abu-Rustum, N.; Alektiar, K.; Makker, V.; Liu, Y.; Zamarin, D.; Friedman, C.; Aghajanian, C.; Ellenson, L.; Weigelt, B.; more...
    Gynecologic Oncology (2022)

    Fulltext@MSK | Save
  • A randomized phase III trial of durvalumab with chemotherapy and bevacizumab, followed by maintenance durvalumab, bevacizumab and olaparib in newly diagnosed advanced ovarian cancer (DUO-O): Updated trial endpoint and inclusion of China cohort
    Meeting Abstract

    Okamoto, A.; Kim, J. W.; Yin, R.; Trillsch, F.; Reuss, A.; Aghajanian, C.; Rubio-PeĢrez, M. J.; Vardar, M. A.; Scambia, G.; Floquet, A.; more...
    Gynecologic Oncology (2022)

    Fulltext@MSK | Save
  • Ten-year conditional probability of survival for patients with ovarian cancer: A new metric for the new millennium
    Meeting Abstract

    Kahn, R.; Filippova, O.; Straubhar, A.; An, A.; Zivanovic, O.; Gardner, G.; O'Cearbhaill, R.; Tew, W.; Sonoda, Y.; Roche, K. L.; more...
    Gynecologic Oncology (2022)

    Fulltext@MSK | Save
  • Reduction in unnecessary postoperative opioid prescription among patients undergoing inpatient gynecologic surgery by standardizing postoperative prescribing practices
    Meeting Abstract

    DiGiacomo, E.; Fearon, N.; Carotenuto, K.; Thompson, E.; Han, M.; Batista, J.; Dearie, H.; Leong, K.; Hurst, S.; Chang, R.; more...
    Gynecologic Oncology (2022)

    Fulltext@MSK | Save
  • Molecular classification of endometrial carcinomas: A single-institution review
    Meeting Abstract

    Rios-Doria, E.; Abu-Rustum, N.; Leitao, M.; Alektiar, K.; Makker, V.; Liu, Y.; Zamarin, D.; Friedman, C.; Aghajanian, C.; Ellenson, L.; more...
    Gynecologic Oncology (2022)

    Fulltext@MSK | Save
  • Predicting outcomes in female germ cell patients using a modified International Germ Cell Cancer Collaborative Group classification system to guide management
    Meeting Abstract

    Manning-Geist, B.; Deng, L.; Knezevic, A.; Bromberg, M.; Funt, S.; Zivanovic, O.; Roche, K. L.; Sonoda, Y.; Gardner, G.; Grisham, R.; more...
    Gynecologic Oncology (2022)

    Fulltext@MSK | Save
  • A preoperative tool for estimating the risk of blood transfusion over an ovarian cancer debulking surgery
    Meeting Abstract

    Kahn, R.; Boerner, T.; An, A.; Gardner, G.; Roche, K. L.; Sonoda, Y.; Zivanovic, O.; Grisham, R.; Abu-Rustum, N.; Chi, D.
    Gynecologic Oncology (2022)

    Fulltext@MSK | Save